Topic: Viral Load

Dr. Peter McCullough recommends nasal hygiene as a primary defense against COVID-19, noting that the virus replicates in the nasal cavity. He suggests using diluted povidone iodine or hydrogen peroxide in a neti pot or spray bottle to kill the virus on contact. McCullough emphasizes that the virus is airborne and that targeting the nasopharynx is more effective than hand sanitizer.

Studies from the Wisconsin Department of Public Health show that viral loads of the Delta variant are equal between vaccinated and unvaccinated individuals, meaning both groups are equally infectious. In the UK, Dr. McCullough reports that 81.8% of those currently dying from COVID-19 are fully vaccinated. He argues that the vaccines have failed to stop the pandemic and that the virus has mutated to thrive in the vaccinated population.

Ivermectin is defended as a safe, Nobel Prize-winning drug with a better safety profile than Tylenol, despite media attempts to vilify it as "horse paste." The drug works by reducing viral load and inflammation, especially when used in combination with zinc and other generic medications. Proponents argue that the suppression of these low-cost treatments is a deliberate effort to maximize pharmaceutical profits and vaccine uptake.

A study from the Cleveland Clinic confirms that natural immunity is robust and durable, with zero reinfections among 2,500 recovered workers. Dr. Peter McCullough asserts that vaccinated individuals can carry a viral load of the Delta variant up to 1,000 times higher than unvaccinated individuals. This data challenges the narrative that the pandemic is driven solely by the unvaccinated.

Harrison Smith cites reports from National Geographic, PBS, and the NIH to document the history of Marek's disease vaccines. The data suggests that while the vaccine reduces symptoms, it does not stop infection, leading to higher viral loads in vaccinated subjects. Smith highlights that the CDC's July 30th report on "breakthrough cases" mirrors the scientific findings regarding leaky vaccines in animal populations.

The discussion covers the massive "load" of spike proteins in vaccines—50 billion in Janssen and 13.1 billion in Pfizer/Moderna—compared to the much smaller amount in a natural infection. Fleming also critiques the Novavax vaccine for using moth cells to grow spike proteins, questioning what foreign DNA might be attached. He argues that healthy people are suffering more because their immune systems mount a massive inflammatory response to this "attack."